"Ketosis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A condition characterized by an abnormally elevated concentration of KETONE BODIES in the blood (acetonemia) or urine (acetonuria). It is a sign of DIABETES COMPLICATION, starvation, alcoholism or a mitochondrial metabolic disturbance (e.g., MAPLE SYRUP URINE DISEASE).
| Descriptor ID |
D007662
|
| MeSH Number(s) |
C18.452.076.176.652
|
| Concept/Terms |
Ketosis- Ketosis
- Ketoacidosis
- Ketoacidoses
Metabolic Ketosis- Metabolic Ketosis
- Ketoses, Metabolic
- Ketosis, Metabolic
- Metabolic Ketoses
- Metabolic Ketoacidosis
- Ketoacidoses, Metabolic
- Ketoacidosis, Metabolic
- Metabolic Ketoacidoses
Acetonemia- Acetonemia
- Acetonemias
- Ketonemia
- Ketonemias
- Ketoacidemia
- Ketoacidemias
Ketonuria- Ketonuria
- Ketonurias
- Ketoaciduria
- Ketoacidurias
- Acetonuria
- Acetonurias
|
Below are MeSH descriptors whose meaning is more general than "Ketosis".
Below are MeSH descriptors whose meaning is more specific than "Ketosis".
This graph shows the total number of publications written about "Ketosis" by people in this website by year, and whether "Ketosis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 1 | 0 | 1 |
| 2012 | 0 | 1 | 1 |
| 2015 | 1 | 0 | 1 |
| 2019 | 1 | 0 | 1 |
| 2021 | 1 | 0 | 1 |
| 2023 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Ketosis" by people in Profiles.
-
Parenteral medication considerations for the ketogenic diet. Am J Health Syst Pharm. 2023 09 22; 80(19):1357-1363.
-
SGLT2 Inhibition by Dapagliflozin Attenuates Diabetic Ketoacidosis in Mice with Type-1 Diabetes. Cardiovasc Drugs Ther. 2022 12; 36(6):1091-1108.
-
Dose-dependent glycometabolic effects of sotagliflozin on type 1 diabetes over 12?weeks: The inTandem4 trial. Diabetes Obes Metab. 2019 11; 21(11):2440-2449.
-
Response to Comment on Mulukutla et al. Autoantibodies to the IA-2 Extracellular Domain Refine the Definition of "A+" Subtypes of Ketosis-Prone Diabetes. Diabetes Care 2018;41:2637-2640. Diabetes Care. 2019 05; 42(5):e82-e83.
-
Six-Year-Old With Altered Mental Status: No "LACk" of Clues. Pediatr Emerg Care. 2016 Mar; 32(3):180-2.
-
Extreme Beta-Cell Deficiency in Pancreata of Dogs with Canine Diabetes. PLoS One. 2015; 10(6):e0129809.
-
Prospective randomized trial of insulin glargine in acute management of diabetic ketoacidosis in the emergency department: a pilot study. Acad Emerg Med. 2015 Jun; 22(6):657-62.
-
Frequency and severity of hypoglycemia in children with beta-blocker-treated long QT syndrome. Heart Rhythm. 2015 Aug; 12(8):1815-9.
-
Ablation of steroid receptor coactivator-3 resembles the human CACT metabolic myopathy. Cell Metab. 2012 May 02; 15(5):752-63.
-
In vivo measurement of brain metabolites using two-dimensional double-quantum MR spectroscopy--exploration of GABA levels in a ketogenic diet. Magn Reson Med. 2003 Apr; 49(4):615-9.